BONRAYBIO USA CORPORATION

BonRay Bio is a medical device company specializing in male reproductive health diagnostics and solutions. Founded in 2016 and based in Taiwan with US operations, the company develops precision medical equipment and automated solutions addressing male infertility. The company's core expertise centers on sperm analysis and optical diagnostic technology. Product portfolio includes routine sperm testing systems, advanced sperm DNA fragmentation detection equipment, and semen processing/washing devices. BonRay Bio serves reproductive medicine clinics, fertility centers, and andrology laboratories globally. The company has secured FDA clearance and holds CE marking, indicating regulatory compliance for US and European markets. Leadership team comprises professionals with over 10 years of medical device development experience. The company positions itself as a leader in sperm diagnostics and optical technology innovation, addressing the growing global demand for male infertility solutions. Recent activities include participation in major international reproductive medicine conferences (ESHRE, CSRM, Medica) and listing on public markets in Taiwan (December 2024). BonRay Bio's LensHooke product line represents their integrated approach to male reproductive diagnostics.